Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map

Area of Science:

• Molecular Biology
• Oncology
• Immunology

Background:

• Signal transducer and activator of transcription 3 (STAT3) activity is crucial for normal tissue repair and wound healing.
• Dysregulated STAT3 activation in cancer cells and the tumor microenvironment mimics inflammatory repair responses, driving tumor progression.
• STAT3 integrates inflammatory signals, making it a key player in both normal repair and neoplastic processes.

Purpose of the Study:

• To review the tumor-modulating activities of STAT3.
• To explore STAT3's role as a signaling node integrating inflammatory responses during wound healing and its implications in cancer.
• To discuss the therapeutic potential of targeting STAT3 and associated pathways in malignancies.

Main Methods:

• Literature review synthesizing current research on STAT3 function in wound healing and cancer.
• Analysis of STAT3's canonical transcriptional and non-transcriptional mechanisms in tumor progression.
• Examination of the convergence of inflammatory cytokines on STAT3 signaling in solid tumors.

Main Results:

• STAT3 promotes cancer stem cell characteristics, survival, proliferation, metastasis, and immune evasion through transcriptional and non-transcriptional pathways.
• Cytoplasmic STAT3 activity contributes to tumor growth via metabolic and other non-transcriptional mechanisms.
• Many cytokines involved in the para-inflammatory state of malignancies converge on dysregulated STAT3 activity.

Conclusions:

• STAT3's dual role in wound healing and cancer progression highlights its significance as a therapeutic target.
• Targeting cytokines, their receptors, and signaling cascades that converge on STAT3 shows promise in clinical trials.
• Interfering with STAT3 activity could simultaneously inhibit cancer cell growth and enhance anti-tumor immunity.